82 related articles for article (PubMed ID: 2703136)
1. [Initial experiences with a monoclonal antibody to the progesterone receptor complex].
Neis KJ; Macher F; Kaul S; Bastert G
Geburtshilfe Frauenheilkd; 1989 Feb; 49 Suppl 1():109-14. PubMed ID: 2703136
[TBL] [Abstract][Full Text] [Related]
2. Estimation of hormone receptor status in fine-needle aspirates and paraffin-embedded sections from breast cancer using the novel rabbit monoclonal antibodies SP1 and SP2.
Cano G; Milanezi F; Leitão D; Ricardo S; Brito MJ; Schmitt FC
Diagn Cytopathol; 2003 Oct; 29(4):207-11. PubMed ID: 14506673
[TBL] [Abstract][Full Text] [Related]
3. Immunocytochemical staining of progesterone receptor in paraffin sections of human breast cancers.
Perrot-Applanat M; Groyer-Picard MT; Vu Hai MT; Pallud C; Spyratos F; Milgrom E
Am J Pathol; 1989 Sep; 135(3):457-68. PubMed ID: 2675623
[TBL] [Abstract][Full Text] [Related]
4. [Human breast cancer embedded in paraffin, fixed in Bouin's fluid. Immunohistochemical analysis of estrogen and progesterone receptors].
Jacquemier J; Boudaoura T; Martin PM; Torrente M; Hassoun J
Ann Pathol; 1991; 11(4):224-30. PubMed ID: 1958256
[TBL] [Abstract][Full Text] [Related]
5. Comparison of an immunocytochemical assay for progesterone receptor with a biochemical method of measurement and immunocytochemical examination of the relationship between progesterone and estrogen receptors.
Berger U; Wilson P; Thethi S; McClelland RA; Greene GL; Coombes RC
Cancer Res; 1989 Sep; 49(18):5176-9. PubMed ID: 2766287
[TBL] [Abstract][Full Text] [Related]
6. Immunocytochemical assay of estrogen and progesterone receptors in fine needle aspirates from breast cancer patients.
Nizzoli R; Bozzetti C; Savoldi L; Manotti L; Naldi N; Camisa R; Soresi AP; Guazzi A; Cocconi G
Acta Cytol; 1994; 38(6):933-8. PubMed ID: 7992582
[TBL] [Abstract][Full Text] [Related]
7. Estrogen receptor immunocytochemistry in paraffin embedded tissues with ER1D5 predicts breast cancer endocrine response more accurately than H222Sp gamma in frozen sections or cytosol-based ligand-binding assays.
Pertschuk LP; Feldman JG; Kim YD; Braithwaite L; Schneider F; Braverman AS; Axiotis C
Cancer; 1996 Jun; 77(12):2514-9. PubMed ID: 8640700
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of new monoclonal antibodies in detection of estrogen receptor, progesterone receptor, and Her2 protein expression in breast carcinoma cell block sections using conventional microscopy and quantitative image analysis.
Hanley KZ; Siddiqui MT; Lawson D; Cohen C; Nassar A
Diagn Cytopathol; 2009 Apr; 37(4):251-7. PubMed ID: 19217031
[TBL] [Abstract][Full Text] [Related]
9. Rabbit monoclonal antibodies show higher sensitivity than mouse monoclonals for estrogen and progesterone receptor evaluation in breast cancer by immunohistochemistry.
Rocha R; Nunes C; Rocha G; Oliveira F; Sanches F; Gobbi H
Pathol Res Pract; 2008; 204(9):655-62. PubMed ID: 18565685
[TBL] [Abstract][Full Text] [Related]
10. Comparison of two antibodies for evaluation of estrogen receptors in paraffin-embedded tumors.
Hendricks JB; Wilkinson EJ
Mod Pathol; 1993 Nov; 6(6):765-70. PubMed ID: 7508117
[TBL] [Abstract][Full Text] [Related]
11. Immunocytochemical localization of progesterone receptors in breast cancer with anti-human receptor monoclonal antibodies.
Elashry-Stowers D; Zava DT; Speers WC; Edwards DP
Cancer Res; 1988 Nov; 48(22):6462-74. PubMed ID: 3180062
[TBL] [Abstract][Full Text] [Related]
12. [Interpretation of the estrogen receptor content of breast cancer].
Tuczek HV; Fritz P; Oeffinger B; Limbach HJ; Mischlinski A; Klein C; Wegner G
Geburtshilfe Frauenheilkd; 1990 Apr; 50(4):314-8. PubMed ID: 2358183
[TBL] [Abstract][Full Text] [Related]
13. [Preoperative immunocytochemical estrogen receptor determination in fine needle aspirates in breast cancer using monoclonal antibodies].
Kübler HC; Kühn W; Rummel HH; Krapfl E; Klinga K
Geburtshilfe Frauenheilkd; 1988 Nov; 48(11):763-7. PubMed ID: 3234709
[TBL] [Abstract][Full Text] [Related]
14. [Hormone receptor determination in breast carcinoma tissue. Comparison of recent immunohistologic techniques with biochemical receptor testing].
Wilkens C; Beck T; Weikel W; Brumm C; Pollow K
Pathologe; 1995 Jul; 16(4):256-61. PubMed ID: 7667207
[TBL] [Abstract][Full Text] [Related]
15. Quantitative assessment of oestrogen and progesterone receptors on fine-needle aspirates and cryostat sections of breast carcinomas: how does this compare with biochemical assays?
Muchiri LW
East Afr Med J; 1993 May; 70(5):280-3. PubMed ID: 8306903
[TBL] [Abstract][Full Text] [Related]
16. Interobserver reproducibility of immunocytochemical estrogen- and progesterone receptor status assessment in breast cancer.
Biesterfeld S; Veuskens U; Schmitz FJ; Amo-Takyi B; Böcking A
Anticancer Res; 1996; 16(5A):2497-500. PubMed ID: 8917341
[TBL] [Abstract][Full Text] [Related]
17. Estimation of PR and ER by immunocytochemistry in breast cancer. Comparison with radioligand binding methods.
Seymour L; Meyer K; Esser J; MacPhail AP; Behr A; Bezwoda WR
Am J Clin Pathol; 1990 Oct; 94(4 Suppl 1):S35-40. PubMed ID: 1699410
[TBL] [Abstract][Full Text] [Related]
18. [Steroid hormone receptors in mammary carcinoma. Immunohistochemical detection and prognostic significance].
Reiner A; Neumeister B; Reiner G; Jakesz R; Kolb R; Schemper M; Spona J
Zentralbl Pathol; 1991; 137(3):233-41. PubMed ID: 1657132
[TBL] [Abstract][Full Text] [Related]
19. Presurgical determination of estrogen receptor status using immunocytochemically stained fine needle aspirate smears in patients with breast cancer.
McClelland RA; Berger U; Wilson P; Powles TJ; Trott PA; Easton D; Gazet JC; Coombes RC
Cancer Res; 1987 Nov; 47(22):6118-22. PubMed ID: 2444337
[TBL] [Abstract][Full Text] [Related]
20. Potential value of estrogen receptor immunocytochemical assay in formalin-fixed breast tumors.
Masood S; Lu L; Rodenroth N
Mod Pathol; 1990 Nov; 3(6):724-8. PubMed ID: 1702213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
